Nearly 6.7 million adults in the U.S. have heart failure, with prevalence expected to rise to 8.5 million by 20301,2. While heart failure is a chronic, progressive disease, advances in technology are ...
GAITHERSBURG, MD (updated) — A Food and Drug Administration (FDA) advisory committee narrowly voted in favor of a novel device that measures pulmonary-artery (PA) pressures in patients with heart ...
CardioMEMS, the company developing a wireless implantable sensor for heart failure patients, has recently announced the results of its nearly three year-long CHAMPION trial. One of the topline results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results